Aiming to bridge the gap in precision health care, Human Health, recognized for its patient-first platform, has secured a €4.7 million seed funding round. The London-based company has innovated a way for individuals to effectively self-manage their health by using advanced AI integrated with patient-reported data. This funding will significantly aid the company in extending its technological capabilities and broadening its reach to more patients. With this move, patients get closer to having accessible, precision-focused healthcare tools, which have long been a privilege of specialized institutions.
Human Health’s funding was driven by LocalGlobe, Airtree, Skip Capital, Aliavia, and Scale Ventures, with individual contributions from influential figures such as Arvind Rajan, Eric Salama, and David Shein. Looking back, the healthcare industry has faced challenges with intertwined systems and lengthy waiting periods across EU nations, leaving patients to deal with fragmented care solutions. Human Health tackles these issues by allowing patients to maintain comprehensive medical records and track their health engagements in an organized manner.
What Are the Platform’s Key Benefits?
Working with AI and patient data, Human Health’s Precision Health platform aims to transform patient experiences. Through capturing real-time health data, patterns in areas like mental health or autoimmune conditions become visible, offering insights that are personalized and actionable. Access to such curated information is designed to empower patients and ease the burdens that typically rest on healthcare professionals.
How Will the Funding Impact Human Health’s Future?
The newly secured funding is directed towards refining the platform’s features and expanding its condition-specific support. It also enables patients to contribute anonymized data to further research efforts, aligning clinical research needs with real-world patient data. Expanding its capabilities, Human Health plans to scale Human Evidence, a B2B platform, which lets life sciences partners utilize large sets of patient-reported data. The company’s focus remains on high-quality, patient-centered healthcare.
The co-founders of Human Health, Kate Lambridis and Georgia Vidler, both former product leaders at Canva, aim to put powerful healthcare decision-making tools in the hands of individuals. This initiative matches broader industry trends where technology serves as a pivotal component in health management. The ability to turn isolated health experiences into comprehensive data helps in forming an insightful narrative for clinicians and patients alike.
The platform also ensures privacy and security, allowing users control over their medical data. These features make it easier for patients to present comprehensive health reports to clinicians without sacrificing privacy. In the words of Kate Lambridis,
“Human Health empowers individuals by giving them control over their health data.”
Meanwhile, Georgia Vidler highlighted that
“Our platform seeks to democratize access to precision healthcare tools.”
The concept of precision healthcare echoes across technological advancements in medical practices. This funding solidifies Human Health’s footing in making health management more accessible. As healthcare continues to evolve with patient-focused innovations, Human Health is positioned to influence how people interact with their health data independently.
